Director/PDMR Shareholding

Seed Innovations Limited
19 January 2024
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

19 January 2024

SEED Innovations Limited

("SEED" or the "Company")

Director Dealings

SEED Innovations Ltd, the AIM-quoted company investment company providing shareholders with exposure to early-stage health, wellness and medical cannabis companies to which, in normal circumstances, they have limited access to, announces that Ed McDermott, Chief Executive Officer, has today purchased  4,675,000 ordinary shares of £0.01p ("Ordinary Shares') at a price of 2 pence per Ordinary Share from his Nominee Account into his Individual Savings Account ("ISA") account,  under a process kown as 'Bed and ISA'.

Following this transaction, Ed McDermott's stake in the company remains the same with 4,680,000 Ordinary Shares, 4,675,000 in his ISA and 5,000 in his Nominee Account, representing approximately 2.25 per cent of the Company's voting rights.

Further details of the share purchase are set out below in the PDMR form which has been made in accordance with the Market Abuse Regulation (EU) no.596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018.

PDMR Notifications

 

Notification of Transactions of Persons Discharging Managerial Responsibility and Persons Closely Associated with them:

 

1.            

Details of the person discharging managerial responsibilities / person closely associated

a.            

Name

Ed McDermott

2.            

Reason for the notification

a.            

Position/status

 Chief Executive Officer

b.            

Initial notification/Amendment

Initial Notification

3.            

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.            

Name

SEED Innovations Limited

b.            

LEI

 

4.            

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.            

Description of the Financial instrument, type of instrument Identification code

Ordinary Shares of £0.01 each

 

b.            

Nature of the transaction

Purchase of Ordinary Shares

c.            

Price(s) and volume(s)

Price(s)

Volume(s)

2p

 

 

4,675,000

 




 

 

d.            

Aggregated information

·Aggregated volume

·Price

 

 

e.            

Date of the transaction

19 January 2024

f.            

Place of the transaction

London Stock Exchange's AIM Market

 

-Ends-

For further information on the Company please visit:  www.seedinnovations.co or contact: 

Ed McDermott

Lance de Jersey

SEED Innovations Ltd

E: info@seedinnovations.co 

 

James Biddle

Roland Cornish

Beaumont Cornish Limited,

Nomad

T: (0)20 7628 3396

 

Isabella Pierre

Damon Heath

Shard Capital Partners LLP

Broker

T: (0)20 7186 9927

Ana Ribeiro

Isabelle Morris

 

St Brides Partners Ltd,

Financial PR

E: seed@stbridespartners.co.uk

 

Beaumont Cornish Limited ("Beaumont Cornish") is the Company's Nominated Adviser and is authorised and regulated by the FCA. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other persons for providing protections afforded to customers of Beaumont Cornish nor for advising them in relation to the proposed arrangements described in this announcement or any matter referred to in it.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings